摘要
目的:平滑肌肌球蛋白轻链激酶(myosin light chain kinase,MLCK)具有激酶活性和非激酶活性,在平滑肌收缩过程中起着关键酶调控的作用。为探寻MLCK的非激酶活性区域对MLCK活性的影响,本实验利用分子生物学技术构建了肌球蛋白轻链激酶CaM结合位点突变体,并纯化出重组的MLCK表达的蛋白质,为深入研究MLCK的非激酶活性在调节平滑肌收缩过程中的分子机制提供了实验基础。方法:利用野生型MLCK全长的cDNA序列设计CaM结合位点的突变引物,利用PCR技术进行定点突变,获得CaM结合位点的突变体(△CaM/MLCK)。在大肠杆菌中表达重组CaM结合位点的突变体(△CaM/MLCK),通过亲和层析及凝胶过滤进行分离纯化重组蛋白,SDS-PAGE检测表达及纯化的重组蛋白。结果:构建重组MLCK钙调蛋白结合位点突变体(△CaM/MLCK),△CaM/MLCK在大肠杆菌中以可溶形式大量表达并得到纯化。结论:成功构建重组MLCK钙调蛋白结合位点突变体(△CaM/MLCK)并获得纯化的表达蛋白质。
Objective: Myosin light chain kinase (MLCK) possesses kinase and non-kinase activities, and both of them play the important roles in the regulation of smooth muscle contraction. To explore the non-kinase activity of MLCK, we constructed the MLCK CaM-binding site mutant, and obtained the recombinant mutant of MLCK. Methods: We designed CaM-binding site mutant primers, and PCR is used to site-directed mutagenesis by using wild-type MLCK,cDNA as the template. CaM-binding site mutant MLCK (△CaM/MLCK) are recombinated and expressed in E. coli, affinity chromatography and gel filtration are used for the separation and purification of expressed protein. SDS-PAGE was used to detect expression and purification of recombinant protein. Results: The recombinant of MLCK calmodulin-binding site mutant (△CaM/MLCK) is constructed, and △CaM/MLCK was expressed in Escherichia coli as a soluble form. Conclusion: The construction and expression of recombinant MLCK calmodulin-binding site mutant (△CaM / MLCK) are successfully established.
出处
《现代生物医学进展》
CAS
2009年第17期3247-3250,共4页
Progress in Modern Biomedicine
基金
国家自然科学基金资助项目(30470394)